- Home
- AWRE vs GNTA Comparison
AWRE vs GNTA Comparison
Compare AWRE & GNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AWRE
- GNTA
- Stock Information
- Founded
- AWRE 1986
- GNTA 2014
- Country
- AWRE United States
- GNTA Italy
- Employees
- AWRE N/A
- GNTA N/A
- Industry
- AWRE Computer Software: Prepackaged Software
- GNTA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- AWRE Technology
- GNTA Health Care
- Exchange
- AWRE Nasdaq
- GNTA Nasdaq
- Market Cap
- AWRE 45.1M
- GNTA 39.4M
- IPO Year
- AWRE 1996
- GNTA 2021
- Fundamental
- Price
- AWRE $2.14
- GNTA $1.84
- Analyst Decision
- AWRE
- GNTA
- Analyst Count
- AWRE 0
- GNTA 0
- Target Price
- AWRE N/A
- GNTA N/A
- AVG Volume (30 Days)
- AWRE 33.2K
- GNTA 866.2K
- Earning Date
- AWRE 10-29-2025
- GNTA 01-01-0001
- Dividend Yield
- AWRE N/A
- GNTA N/A
- EPS Growth
- AWRE N/A
- GNTA N/A
- EPS
- AWRE N/A
- GNTA N/A
- Revenue
- AWRE $17,428,000.00
- GNTA N/A
- Revenue This Year
- AWRE N/A
- GNTA N/A
- Revenue Next Year
- AWRE N/A
- GNTA N/A
- P/E Ratio
- AWRE N/A
- GNTA N/A
- Revenue Growth
- AWRE 2.72
- GNTA N/A
- 52 Week Low
- AWRE $1.37
- GNTA $1.35
- 52 Week High
- AWRE $2.95
- GNTA $10.00
- Technical
- Relative Strength Index (RSI)
- AWRE 42.45
- GNTA 39.44
- Support Level
- AWRE $2.09
- GNTA $1.35
- Resistance Level
- AWRE $2.25
- GNTA $2.32
- Average True Range (ATR)
- AWRE 0.13
- GNTA 0.24
- MACD
- AWRE -0.02
- GNTA -0.02
- Stochastic Oscillator
- AWRE 18.75
- GNTA 41.67
About AWRE Aware Inc.
Aware Inc is a provider of software and services to the biometrics industry. The company's software products are used in government and commercial biometrics systems to identify or authenticate people. The government applications of biometrics systems include border control, visa applicant screening, law enforcement, national defense, intelligence, secure credentialing, access control, and background checks. Its commercial applications include user authentication for login to mobile devices, computers, networks, and software programs, user authentication for financial transactions and purchases. Its geographical segments include the United States, the United Kingdom, and the Rest of the world, out of which it derives maximum revenue from United States.
About GNTA Genenta Science S.p.A.
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain.